Small Arms Light Weapons Market Size is Projected to Witness Significant Growth till 2024

 The global Small Arms Light Weapons Market is expected to reach USD 25.76 billion by 2024, according to a new report by Grand View Research, Inc. The increasing issues on human rights and safety and security are expected to drive the demand. The increasing effects of urban warfare along with increasing terrorism incidents have also led to the development of the small arms light weapons across various regions. An increase in the urban warfare along with increased terrorist activity is anticipated to propel the market growth. The development of light-weight weapons for further enhancement of defense system is an ongoing trend in the developed countries.

Increasing criminal activities and human rights violations have resulted in the increased efforts for the technology advancements and modernization of the weapons utilized by law enforcement. The Combat Development and Integration Command’s Fires and Maneuver Integration Division of marines introduced the small arms modernization strategy which is expected to focus on updating and developing the current weapons in short-term and futuristic systems that could hit the fleet in the 2020s.

The governments of various countries are also investing their resources for the development of highly sophisticated weapon accessories such as night vision devices, laser rangefinders, weapon sights, aiming lasers, and fire control systems. High investment in the defense Research & Development (R&D) for shoulder –wired weapons made for developing a highly robust, reliable, and durable weapons system has also catapulted the demand for light weapons in military applications. The limited defense budget to boost the development of defense system is expected to hinder the market growth.

Request a sample copy or view summary of this report@
http://www.grandviewresearch.com/industry-analysis/small-arms-light-weapons-salw-market

Further key findings from the study suggest:

• In 2015, light weapons market accounted for over 60% of the overall market share and is also expected to significantly growth over the forecast period. The implementation of modernization programs for police and the military forces is expected to drive the growth.
• Rifles in small arms segment are expected to witness a significant growth at a CAGR of over 20% over the forecast period. The increasing interest of civilians in the shooting sports is expected to be the reason for growth.
• Grenade and grenade launchers are expected to witness enormous growth in the light weapons segment owing to increased stress between countries and increased development of grenade launchers
• The military application segment is anticipated to witness substantial growth and is estimated to reach over USD 13.0 billion by 2024. The widespread geographic presence of terrorism and human rights violation had led to the increased demand of light weapons market. Increased violation of civilians rights and law enforcement regulations have also triggered its growth.
• The Asia Pacific SALW market is anticipated to grow at a CAGR of over 25% over the forecast period. Increasing technology and economic developments in the emerging countries such as China and India with their cross-border disputes has contributed to the growth.
• Notable companies operating in the SALW market include Raytheon, Berette S.p.A., GLOCK Ges m.b.H., and FN Herstal SA

 About Us:
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, the company offers market intelligence studies ensuring relevant and fact-based research across a range of industries including technology, chemicals, materials, healthcare and energy.

Contact:
Sherry James
Corporate Sales Specialist, USA
Grand View Research, Inc
Phone: 1-415- 349-0058
Toll Free: 1-888- 202-9519
Email: sales@grandviewresearch.com
For More Information: https://www.grandviewresearch.com

Bioprosthetics Market: Growth Factors & Competitive Analysis, 2024

The global Bioprosthetics Market is expected to reach USD 6.41 billion by 2024, according to a new report by Grand View Research, Inc. The unprecedented upward shift in the lifestyle-associated habits leading to the high prevalence of cardiovascular diseases coupled with the increasing geriatric population base,which is highly susceptible to developing cardiac impairments and tissue damage,are presumed to impel the demand for the bioprosthetics market during the forecast period.

Lower biocompatibility, aesthetics, and strength exhibited by the synthetic material-based prosthetics indicate the indisputable requirement for incorporating bioprosthetics; consequentially, the increasing need for the tissue-engineered autologous, allogenic or xenograft products is anticipated to present the market with lucrative growth opportunities.

The growth in the demand for bioprostheses is attributed mainly to technological advancements comprising trans catheter valve fabrication technology, the construction of which involves a multidisciplinary approach, wherein wide-ranging technologies borrowed from varied devices including balloon angioplasty and coronary stents as well as medical disciplines, such as cardiac surgery and interventional cardiology, are merged to introduce a revolutionary quantum leap in the transcatheter valve replacement procedures. Moreover, a combination of the non-invasive imaging techniques, such as, echo cardiography angiography, MRI, and CT, are increasingly being employed, which allows the surgeons to visualize both the device and the anatomy of the patient thus eliminating the need to conduct an open heart surgery.

Browse Details of Report @  
http://www.grandviewresearch.com/industry-analysis/bioprosthetics-market

Further key findings from the study suggest:

• The allograft segment is expected to exhibit growth at a significant CAGR of over 10.0% during the forecast period. This is a consequence of the following associated advantages such as reduced surgical time, smaller incisions, greater physiological acceptability, availability of larger grafts, and a safer alternative to procedures that employ synthetic grafts as they pose a high risk of complications under anesthesia

• The plastic surgery and wound healing segment is anticipated to witness an exponential CAGR of over 11.0% in the application segment over the forecast period. This substantial share can be attributed to the increasing number of soft tissue repair procedures, such as in hernia and abdominal wall reconstruction

•  Additionally, as per a research published by the NCBI, the increase in case complexities drive the need to apply a multidisciplinary approach in performing the above-mentioned procedures, which augments the use of these bioprosthetics meshes to decrease the morbidity associated with chronic impairments

• In 2015, Europe dominated the overall bioprosthetics market at over 40.0%. Moreover, the subsequent changes in the demographic trends, such as the frequent product approvals, increasing geriatric population base, lifestyle-associated changes, and the high awareness levels pertaining to the availability of bioprosthetics solutions are anticipated to drive the market growth in this region

• For instance, In April 2016, St. Jude Medical, Inc. announced the European launch of Trifecta Surgical Valve to provide enhanced alternatives to patients requiring aortic valve replacements. This launch resulted in the expansion of the existing product portfolio of St. Jude Medical, Inc. in Europe

• Some leading players in this industry include Edwards Lifesciences Corporation, St.Jude Medical, Inc., Sorin Group, CryoLife, Inc., Braile Biomedica, Inc., and Medtronic Plc; these players are increasingly involved in adopting collaborative strategies and launching frequent product approvals to facilitate business expansion

• For instance, in March 2016, Edwards Lifesciences Corporation received an approval for the SAPIEN 3 Valve in Japan for the treatment of patients suffering from aortic stenosis. Additionally, the rising involvement of the players in this vertical toward developing and enhancing the supply of bioprosthetics through strategic alliances is likely to provide the market with a high potential growth platform in the future

 

About Us:
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, the company offers market intelligence studies ensuring relevant and fact-based research across a range of industries including technology, chemicals, materials, healthcare and energy.

Contact:
Sherry James
Corporate Sales Specialist, USA
Grand View Research, Inc
Phone: 1-415- 349-0058
Toll Free: 1-888- 202-9519
Email: sales@grandviewresearch.com
For More Information: https://www.grandviewresearch.com

APAC In Vitro Diagnostics Market - Top Companies : Danaher Corporation, Affymetrix, Inc., Abbott Laboratories, Alere, Inc.

The Asia Pacific In Vitro Diagnostics (IVD) market is expected to reach USD 33.4 billion by 2024, according to a new report by Grand View Research, Inc. The Asia Pacific IVD market is anticipated to witness lucrative growth during the period 2016 to 2024. The growth of the market is attributed to an increase in the number of infectious and chronic diseases as well as technological advancements in the field of in vitro diagnostics.

Additionally, factors such as an increase in per capita income, the swiftly growing economies of India and China, increase in gross domestic product, and the rising disposable income are expected to be opportunistic for the industry growth. However, the presence of stringent regulatory policies, inadequate budget, and reimbursement issues are likely to hinder the growth of the market in the near future.

The Asia Pacific IVD market is segmented into technology, application, end-user, and region. Based on the product type, the industry is categorized into reagents, instruments, and services. The reagents market is estimated to hold the largest revenue share owing to the extensive use of reagents in diagnostics.

The molecular diagnostics segment is anticipated to be the fastest growing segment. On the basis of application, the market is categorized into infectious diseases, oncology, cardiology, nephrology, autoimmune diseases, HIV and drug testing. The large market share of this segment is attributed to the rising prevalence of infectious diseases. End-user applications include hospitals, laboratories, homecare diagnostics, and research institutes among others.

Request a sample copy or view summary of this report @ http://www.grandviewresearch.com/industry-analysis/asia-pacific-in-vitro-diagnostics-ivd-market

Further key findings from the study suggest:

• In terms of growth, the Chinese in vitro diagnostics industry is anticipated to witness rapid growth in the next few years. Factors attributing to the growth of this industry in China include the increasing healthcare expenditure, GDP growth, rising population base, and more favorable health insurance coverage.
• Infectious diseases segment was identified as the largest revenue generating category in the application segment and is estimated to maintain its position due to the continual rise in the number of diseases estimated for the next few years.
• The in vitro diagnostics industry comprises several local as well as global players. Some of the major players in this industry include Danaher Corporation, Affymetrix, Inc., Abbott Laboratories, Alere, Inc., Roche Diagnostics among others.
• In order to gain a major share in the industry, the companies adopted both organic as well as inorganic growth strategies. The key strategies undertaken by the companies are new product development, mergers, collaborations, partnerships, geographical expansions, and acquisitions. For instance,in October 2015, Cepheid announced the launch of its newly developed, FDA approved test ‘Xpert TV’, an in-vitro diagnostic test for the accurate identification of Trichomoniasis in female patients.
  
  

About Us:
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, the company offers market intelligence studies ensuring relevant and fact-based research across a range of industries including technology, chemicals, materials, healthcare and energy.

Contact:
Sherry James
Corporate Sales Specialist, USA
Grand View Research, Inc
Phone: 1-415- 349-0058
Toll Free: 1-888- 202-9519
Email: sales@grandviewresearch.com
For More Information: https://www.grandviewresearch.com

Global Fondaparinux Market Analysis Report by Product

The global Fondaparinux Market is expected to reach USD 686.3 million by 2024, according to a new report by Grand View Research, Inc. Fondaparinux is majorly used during knee and hip replacement surgeries. Arixtra, manufactured by GSK group of companies is the branded drug of Fondaparinux. The drug witnessed patent expiry in 2002. As the active molecule is highly complex to manufacture, it faced low generic competition until 2011. Generic manufacturer companies, such as Alchemia Ltd. and Apotex, Inc., received the Abbreviated New Drug Application approval in 2011 and instantly started the production of generic drugs.

Fondaparinux is used as an anticoagulant and shows improved survival compared with low-molecular-weight heparin. It is used for the prevention of Deep Vein Thrombosis (DVT) and Pulmonary Embolism (PE) and is administered subcutaneously. Moreover, Fondaparinux lowers the risk of ischemic events

The increasing collaboration between the key players for acquiring the Intellectual Property Rights (IPRs) in order to manufacture the molecule through patented technology is expected to drive growth. For instance, in July 2016 Dr. Reddy’s Laboratories Ltd. entered into an agreement with Alchemia Ltd. to purchase the IPRs of fondaparinux sodium for USD 17.5 million. In September 2014, Mylan N.V. purchased branded and generic versions of fondaparinux sodium from Aspen Global, Inc. for USD 225 million. The deal gave Mylan N.V. access to one of the two generics indicated for the treatment of PE.

Browse Details of Report @ http://www.grandviewresearch.com/industry-analysis/fondaparinux-market

Further key Findings From the Study Suggest:

• Generics and authorized generics of Arixtra (fondaparinux sodium) dominated the market in 2015 with share of over 65.0%
• The introduction of generic drugs in the market by Apotex, Inc., Dr. Reddy’s, and Mylan N.V. is expected to drive the market growth.
• Branded drug Arixtra is however anticipated to witness declining growth rate majorly owing to patent expiration, high cost, and introduction of low-cost alternatives
• North America held the largest market share of the global market in 2015. Key factors attributing to the dominance include constantly increasing geriatric population, rising prevalence of thrombosis, and the introduction of low-cost generics of Fondaparinux in the U.S.
• In addition, the increasing number of awareness initiatives undertaken by government and nongovernment organizations for DVT and PE is driving the growth of the market in the North American region.
• China’s huge population base with the rising disposable income coupled with the increased burden of chronic diseases is expected to be one of the major drivers for the Chinese market over the forecast period.
• Moreover, the presence of local active pharmaceutical ingredients manufacturers and contract research organizations in China increased the number of foreign investments in the country. As a result, China is estimated to grow at CAGR of 21.2% till 2024
• Major companies identified in the market include Dr. Reddy’s Laboratories, Inc., GSK group of companies, Mylan N.V., and Alchemia among others.
• The Fondaparinux market is a consolidated market and is marked by the presence of mergers and acquisitions

 About Us:

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, the company offers market intelligence studies ensuring relevant and fact-based research across a range of industries including technology, chemicals, materials, healthcare and energy.

Contact:
Sherry James
Corporate Sales Specialist, USA
Grand View Research, Inc
Phone: 1-415- 349-0058
Toll Free: 1-888- 202-9519
Email: sales@grandviewresearch.com
For More Information: https://www.grandviewresearch.com

North America & Europe Stroke Diagnostics Market Size is Estimated to Attain $2.35 Billion By 2024

 The North America And Europe Stroke Diagnostics Market size is expected to reach USD 2.35 billion by 2025, according to a new report by Grand View Research, Inc. It is anticipated to expand at a CAGR of 6.2% over the forecast period. Rising geriatric population in countries like U.S. and Germanyhas led to high growth of the market. Geriatric population in U.S. is anticipated to rise to around 98 million by 2060.

Unhealthy lifestyle is another significant factor driving demand for stroke diagnostic products. Unhealthy lifestyles and physical inactivity are attributed to rising cases of diabetes, obesity, and other such health conditions. According to the Centers for Disease Control and Prevention (CDC) 2017 statistics, over 36% of U.S. population is obese. Diabetes is also one of the prevalent health conditions in Europe. Thus, increasing incidence of such disease conditions has propelled the market for stroke diagnostics.

Rise in awareness among people pertaining to stroke diagnosis and treatment is also expected to foster market growth. In 2011, the Department of Health and Human Services in U.S. started the Million Hearts program as an initiative to avert strokes by 2017. Building on the experience of the first five years the program is committed to work towards prevention of 1 million strokes. The program aims at taking steps to prevent cardiovascular diseases, such as strokes and improving overall public health. Such awareness programs undertaken by government are likely to boost the market growth.

Browse Details of Report @ https://www.grandviewresearch.com/industry-analysis/north-america-europe-stroke-diagnostics-marke

Further key findings from the study suggest:

• CT scan was the dominant technology segment in 2016 due to its high usage rate for stroke evaluation and is considered as a preliminary testing technique
• Carotid ultrasound segment is anticipated to showcase lucrative CAGR during the forecast period owing to the advantages like noninvasive technique and cost-effectiveness
• MRI segment held significant revenue share in 2016 owing to innovations and advancements for improved diagnosis
• Cerebral angiography is expected to exhibit lucrative growth during the forecast period owing to rising adoption of minimally invasive diagnostic techniques
• North America held the largest market share in 2016 due to rise in unhealthy lifestyles leading to obesity and diabetes, especially in U.S. Europe contributed to significant market share due to increasing geriatric population in Germany
• Some of the key manufacturers in the North America and Europe stroke diagnostics market are Cordis Corporation, Siemens Healthineers, GE Healthcare, Toshiba Medical Systems Corporation, Boston Scientific Corporation, Hitachi Medical Systems, Neusoft Medical Systems, and Philips Healthcare.

About Us:
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, the company offers market intelligence studies ensuring relevant and fact-based research across a range of industries including technology, chemicals, materials, healthcare and energy.

Contact:
Sherry James
Corporate Sales Specialist, USA
Grand View Research, Inc
Phone: 1-415- 349-0058
Toll Free: 1-888- 202-9519
Email: sales@grandviewresearch.com
For More Information: https://www.grandviewresearch.com

Healthcare Biometric Market Worth $14.5 Billion By 2025 | CAGR 24.2%

 The global Healthcare Biometric Market is expected to reach USD 14.5 billion by 2025, according to a new report by Grand View Research, Inc. The migration of health system and hospitals to Electronic Health Records (EHR) and computerized physician order entry is expected to propel the demand for healthcare biometrics over the forecast period.

As more Healthcare Information Exchanges (HIE) are built across the network to coordinate care, the demand for technologies to combat data corruption and unauthorized access is expected to increase, thereby contributing to the market growth of healthcare biometrics during the forecast period.

Implementation of biometrics is expected to increase the security for patients, doctors, and nurses. The HIPPA has imposed stringent new regulations to safeguard confidentiality and privacy of patient information. These regulations are also expected to drive the deployment of biometrics in healthcare system, thereby contributing to the market growth over the forecast period.

Improvements in the existing technologies and the development of multipurpose authentication devices are expected to facilitate commercialization of advanced products. As a result, adoption of these devices is expected to escalate in the healthcare space in the near future.

The rise of consumerism in healthcare and increase in disposable income in emerging countries is also expected to boost the adoption of new technologies such as biometrics by health system, thereby propelling the market growth healthcare biometrics market during the forecast period.

Request a free sample copy or view report summary: Healthcare Biometric Market Report

Healthcare Biometric Market Report Highlights

• The global face recognition technology market is anticipated to reach over 2.0 billion by 2025, at a CAGR of 23.0% from 2017 to 2025
• In terms of technology, others segment which includes DNA analysis, retina analysis, and ECG analysis is expected to show the fastest growth during the forecast period
• In terms of technology, iris recognition is also expected to show lucrative growth owing to its uniqueness as compared to other technologies
• North America is expected to dominate the healthcare biometric market during the forecast period
• Asia pacific is expected to show the fastest growth in healthcare biometric market over the forecast period
• The market is partially consolidated and competitive in nature, with presence of global multinational players
• Some of the key companies present in the market include NEC Corporation, Fujitsu, 3M, MorphoTrust, Imprivata, Inc., Suprema, BIO-key International, Crossmatch, Hitachi Ltd., Integrated Biometrics, Genkey Solutions B.V., Agnitio, Nuance Communications, Inc., and Qualcomm Technologies, Inc.

 About Us:
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, the company offers market intelligence studies ensuring relevant and fact-based research across a range of industries including technology, chemicals, materials, healthcare and energy.

Contact:
Sherry James
Corporate Sales Specialist, USA
Grand View Research, Inc
Phone: 1-415- 349-0058
Toll Free: 1-888- 202-9519
Email: sales@grandviewresearch.com
For More Information: https://www.grandviewresearch.com

Radiology Information System Market 2019 – 2026 - Top Companies : Allscripts; Cerner Corporation; Epic Systems Corporation; McKesson Corporation

The global Radiology Information System Market size is expected to reach USD 1.15 billion by 2026, according to a new report by Grand View Research, Inc. It is anticipated to expand at a CAGR of 7.7% during the forecast period. The market is majorly driven by an increase in the adoption of advanced technologies in healthcare facilities. Growing usage of digital healthcare infrastructure, which helps collect and manage information generated by hospitals, clinics, and institutes, has enhanced the efficiency and effectiveness of their services. Moreover, an increase in the number of patients suffering from chronic diseases coupled with rising demand for cloud-based systems are expected to boost the market growth.

Potential opportunities for healthcare IT in reducing operating costs incurred while record keeping and meeting regulatory standards for privacy, as well as efficient hospital workflow management, are among other factors driving the uptake of Radiology Information System (RIS). Furthermore, it is expected that these systems will, in the long run, save money and allow organizations to earn significant profits.

Cloud-based RIS can be integrated with Artificial Intelligence (AI) algorithms to form a comprehensive radiology software. Such AI tools, allow physicians to provide accurate and faster diagnosis and can be integrated with any third party AI tool. For instance, the RADSpa by Telerad Tech is a software platform consisting of RADSpa PACS and Viewer & RADSpa 2D/MPR/MIP/3D Viewer that enables receiving, storing and sending DICOM images along with managing the physician workflow.

Request a free sample copy or view report summary: Radiology Information System Market Report

Radiology Information System Market Report Highlights

• Web-based systems deployment mode held majority of the market share in 2018, due to workflow enhancement features such as scheduling, document imaging, automated insurance eligibility functions, and billing
• Integrated radiology information system accounted for the largest market share in the year 2018. It offers data analysis with the help of Picture Archiving and Communication System (PACS) for the development of IT service models
• Hospitals, emergency healthcare service providers, and physicians are a few RIS end-users. Hospitals majorly prefer radiology solutions for patient scheduling, appointments, and for tracking patient history and records
• North America led the radiology information system market in 2018 in terms of revenue attributed to the technological advancements and presence of major market players
• Some of the key market players are Allscripts; Cerner Corporation; Epic Systems Corporation; McKesson Corporation; GE Healthcare; Siemens Healthcare; Philips Healthcare; Merge Healthcare; and MedInformatix, Inc.

Teleradiology Market 2020 – 2027 - Top Companies : 4ways Healthcare Ltd.; HealthWatch TeleDiagnostics Pvt. Ltd.; RamSoft, Inc.; Everlight Radiology

 The global Teleradiology Market size is estimated to reach USD 10.9 billion by 2027 registering a CAGR of 13.9% over the forecast period, according to a new report by Grand View Research, Inc. Shortage of radiologists, coupled with continuously rising demand for imaging procedures, is expected to drive the market. Despite a significant increase in the installation of radiology equipment in countries such as U.K., U.S., and Singapore over the past few years, there is still a high unmet need for diagnostics imaging. For instance, as per a report by the National Health Service (NHS), the average waiting time for an MRI test in England was reported to be 21 days in 2018.

In addition, legislative amendments made by various governments worldwide for diagnostic imaging services will enhance the growth of teleradiology during the forecast period. For instance, amendments in Australia’s Health Insurance Act 1973 for diagnostic imaging have enabled Medicare funding for these diagnostic imaging services since March 2008. This has allowed better access to diagnostic imaging for various conditions. North America is a major market for teleradiology and accounted for 39.5% of the global revenue in 2019 due to factors such as greater funding for R&D, rising patient awareness levels, and growing cancer prevalence.

The regional market is likely to expand further on account of favorable government initiatives for improving the healthcare facilities in rural areas and increased healthcare expenditure. Asia Pacific is expected to witness the fastest growth over the forecast period, exhibiting a CAGR of 14.9%. Rising demand for innovative and advanced medical platforms, coupled with rapidly growing healthcare infrastructure, supports the growth in this region. In addition, presence of target population and need for improved disease diagnosis are anticipated to drive the demand for teleradiology equipment in APAC.

Request a sample copy or view summary of this report@
https://www.grandviewresearch.com/industry-analysis/teleradiology-market

Further key findings from the report suggest:

• X-ray held the largest teleradiology market share in 2019 owing to its wide application scope, such as in the detection of dental injuries and fractures in bones. Growing demand for bedside imaging and core diagnostics and introduction of novel technologies are expected to further boost segment growth
• CT scan is expected to witness the fastest growth over forecast period. Extensive usage, faster testing, high-resolution imaging capacity, and advent of new generation systems such as 4D are some of the factors responsible for segment growth
• Based on end use, hospitals held the largest market share in 2019. Large patient base, building financial capacity, and receptivity to advanced technologies are the factors responsible for uptake of radiology products in hospitals
• North America held the largest share in the market for teleradiology in 2019 due to wide usage of advanced technologies, presence of key companies, and established healthcare infrastructure in the region
• Asia Pacific is expected to be the fastest-growing region over the forecast period due to supportive government regulations for the expansion of teleradiology and quick adoption of new technologies
• Some of the prominent companies are 4ways Healthcare Ltd.; HealthWatch TeleDiagnostics Pvt. Ltd.; RamSoft, Inc.; Everlight Radiology; Virtual Radiologic; Agfa-Gevaert N.V.; ONARD; Teleradiology Solutions; and Global Diagnostics. Most of these companies focus on expanding their product portfolios and entering in untapped markets such as Asia Pacific.

 About Us:
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, the company offers market intelligence studies ensuring relevant and fact-based research across a range of industries including technology, chemicals, materials, healthcare and energy.

Contact:
Sherry James
Corporate Sales Specialist, USA
Grand View Research, Inc
Phone: 1-415- 349-0058
Toll Free: 1-888- 202-9519
Email: sales@grandviewresearch.com
For More Information: https://www.grandviewresearch.com

Preclinical Imaging Market To Be Worth $3.6 Billion By 2024

The global Preclinical Imaging Market is expected to reach around USD 3.6 billion by the year 2024, according to a report performed by Grand View Research, Inc. The swift increase in the number of clinical research organizations (CROs), pharmaceutical companies, and research and development organizations is propelling the demand for preclinical imaging.

Heavy investments in research and development are encouraging research projects worldwide. As a result, the demand for Preclinical imaging is steadily increasing. Pharmaceuticals, biotechnology, life sciences, medical devices, and cosmetics are the wide application areas, where imaging modalities are widely used in research and development. Furthermore, veterinary hospitals and educational institutions also create an additional demand for this market.

North America comprises the U.S. and Canada markets. North America and Europe together accounted for the largest market share in 2015. The increased research and development funding coupled with the presence of a highly developed research infrastructure is accelerating the growth of the market in Europe and North America.

On the other hand, the governing stringent regulatory guidelines are restricting the growth of the market in North America. Asia Pacific is expected to show the fastest growth rate during the forecast period owing to the easy availability of resources, the presence of an advanced research infrastructure, and the allocation of government funds for R&D activities.

Request a sample copy or view summary of this report@ http://www.grandviewresearch.com/industry-analysis/preclinical-imaging-market

Further key findings from the study suggest:

• The optical imaging devices segment captured the largest market share of the overall market in 2015. The largest market share was mainly attributed to the extensive application of these devices in small animal imaging and research projects.
• The multimodal imaging devices segment is anticipated to show a significant growth rate from 2016 to 2024. The increasing adoption of these devices owing to the integration of multiple imaging modalities into a single unit is the major factor expected to drive the growth of this segment during the forecast period.
• The reagents segment accounted for a significant market share in 2015 as these products are purchased repeatedly, unlike in the case of imaging devices
• North America captured the largest market share of around 35% in 2015. The market is expected to maintain its dominance during the forecast period. Well-established research infrastructure, the growing number of research and development activities, and the rising investments in R&D are some of the factors supporting the growth of the market in this region.
• Asia Pacific is anticipated to show a significant growth rate from 2016 to 2024 owing to the rapidly expanding contract research organization (CRO) industry in this region
• The exit of the major players from the market is creating growth opportunities for the other smaller, domestic Preclinical imaging system manufacturers
• The major market players include Bruker Corporation, Siemens A.G., General Electric(GE), TriFoil Imaging, PerkinElmer, Inc., VisualSonics, Inc. (Fujifilm), Mediso Ltd., MILabs B.V., and Agilent Technologies.

 About Us:
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, the company offers market intelligence studies ensuring relevant and fact-based research across a range of industries including technology, chemicals, materials, healthcare and energy.

Contact:
Sherry James
Corporate Sales Specialist, USA
Grand View Research, Inc
Phone: 1-415- 349-0058
Toll Free: 1-888- 202-9519
Email: sales@grandviewresearch.com
For More Information: https://www.grandviewresearch.com

Protein Expression Market: Growth Factors & Competitive Analysis, 2018-2025

The global Protein Expression Market is expected to reach USD 3.0 billion by the year 2025 growing at a CAGR of 10.4%, according to a new report by Grand View Research, Inc. The growing demand for biologics and expansion of the biopharmaceutical industry have resulted in massive growth of the protein expression market. Rising demand for therapeutic proteins such as insulin, hormones, monoclonal antibodies and vaccines is a major factor that propels growth of the market during forecast period. Thus, many biotechnology and pharmaceuticals companies have begun to concentrate on the development and manufacturing of advanced therapeutic proteins for the treatment of severe chronic diseases such as cancer, hemophilia, infectious diseases, anemia, and multiple sclerosis.

Increasing investment in the R&D, by biotechnology and pharmaceutical companies, is another major factor supporting the sector growth. The availability of new and advanced technologies to cater the needs of drugs & biologics product manufacturers boosts the adoption of protein expression products for research and manufacturing applications. In addition, several pharmaceutical and biotechnology manufacturers are undergoing collaborations and partnerships to achieve leadership in the sector. For instance, in December 2016, Takara Bio, Inc. signed a merger agreement with Rubicon Genomics, Inc. to strengthen its genomics business.

Browse Details of Report @ http://www.grandviewresearch.com/industry-analysis/protein-expression-market

Further Key Findings From The Report Suggest:

• Prokaryotic expression systems segment was the largest revenue-generating amongst others owing to its large application in biologics and drug productions
• Mammalian cell expression systems is the fastest growing segment of the protein expression market owing to its growing demand for proteomics research and biologics manufacturing
• Reagents segment held the largest revenue share in the market, which is attributed to its repetitive purchase fortherapeutic, industrial, and research applications
• The services segment is projected to grow at highest rate due to increasing trend of outsourcing of protein expression services by research labs and drug manufacturers
• Therapeutic application segment was leading in 2016, due to high demand of therapeutic proteins for the treatment of cancer, infectious diseases, anemia, hemophilia, and multiple sclerosis
• The pharmaceutical and biotechnological companies segment dominated the sector in terms of revenue in 2016 due to rising focus on proteomics research and increasing production of biologics products
• North America was the leading regional market in 2016 and is expected to maintain its dominance during the forecast period, because of the presence of large number of biopharmaceutical and biotechnology companies in this region
• The Asia Pacific region is projected to grow at a highest CAGR during the forecast period owing to untapped opportunities in the developing countries including China and India

• Some of the major players include Agilent Technologies, Inc., Bio-Rad Laboratories, Inc., Thermo Fisher Scientific Inc., Merck KGaA, New England Biolabs, Promega Corporation, Qiagen, and Takara Bio, Inc.  

 About Us:
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, the company offers market intelligence studies ensuring relevant and fact-based research across a range of industries including technology, chemicals, materials, healthcare and energy.

Contact:
Sherry James
Corporate Sales Specialist, USA
Grand View Research, Inc
Phone: 1-415- 349-0058
Toll Free: 1-888- 202-9519
Email: sales@grandviewresearch.com
For More Information: https://www.grandviewresearch.com